The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered. [electronic resource]
Publication details: HemaSphere Jun 2018Description: e52 p. digitalISSN:- 2572-9241
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.